An AI platform to accelerate drug discovery: integrating target discovery, molecular generation, and simulation
This invited narrative review and platform perspective summarizes the concept and current implementation of an integrated Drug Discovery DX Platform (DXPF) that connects disease information and patient omics data to target gene/protein discovery, lead compound generation, and simulation-based evaluation.